CAS: 1493764-08-1; N-(4-(1H-Imidazol-1-yl)Benzyl)-2-(Butylamino)-4-((Trans-4-Hydroxycyclohexyl)Amino)Pyrimidine-5-Carboxamide

结构式图片

欧盟法规

C&L通报

上下游产品

2,4-dichloro-5-pyrimidinecarboxylic acid methyl ester -1H-imidazole1-4-(aminomethyl)phenyl-1H-imidazole 2,4-dichloropyrimidine-5-carbonyl chloride

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:CN-108379591-B
    优先权日:2018-04-03
    标 题 :Synthesis of Immune Agonist Targeting Compounds and Their Applications

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Zhang W, McIver AL, Stashko MA, Deryckere D, Branchford BR, Hunter D, Kireev D, Miley MJ, Norris-Drouin J, Stewart WM, Lee M, Sather S, Zhou Y, Di Paola JA, Machius M, Janzen WP, Earp HS, Graham DK, Frye SV, Wang X. Discovery of Mer Specific Tyrosine Kinase Inhibitors for the Treatment and Prevention of Thrombosis. J Med Chem. 2013 Nov 20. 56(23): 9693–9700.

    合成参考文献


    参考文献:10.1124/mol.119.115964
    摘要:Lee TD, Lee OW, Brimacombe KR, Chen L, Guha R, Lusvarghi S, Tebase BG, Klumpp-Thomas C, Robey RW, Ambudkar SV, Shen M, Gottesman MM, Hall MD. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular Pharmacology. 2019 Nov;96(5):629–40. doi: 10.1124/mol.119.115964.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知